Annis Gardner Whiting Capital Advisors’s Sanofi SNY Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-196	Closed	-$9.44K	–	1110
2026 Q1	$9.44K	Sell	196 -500	-72%	-$23.3K	﹤0.01%	875
2025 Q4	$33.7K	Buy	696 +588	+544%	+$29.1K	0.01%	586
2025 Q3	$5.1K	Sell	108 -904	-89%	-$43.6K	﹤0.01%	785
2025 Q2	$48.9K	Buy	1,012 +904	+837%	+$46.2K	0.02%	425
2025 Q1	$5.99K	Hold	108	–	–	﹤0.01%	606
2024 Q4	$5.21K	Hold	108	–	–	﹤0.01%	609
2024 Q3	$6.22K	Hold	108	–	–	﹤0.01%	613
2024 Q2	$5.24K	Hold	108	–	–	﹤0.01%	770
2024 Q1	$5.25K	Hold	108	–	–	﹤0.01%	755
2023 Q4	$5.37K	Hold	108	–	–	﹤0.01%	539
2023 Q3	$5.79K	Buy	+108	New	+$5.76K	﹤0.01%	515

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's SNY Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Sanofi (SNY) in Q2 2026, closing a stake of 196 shares — an estimated $9.44K sold.

Annis Gardner Whiting Capital Advisors first reported a position in SNY in Q3 2023 and held it in 11 quarters. The position peaked at $48.9K in Q2 2025. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Annis Gardner Whiting Capital Advisors reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
Annis Gardner Whiting Capital Advisors sold 196 Sanofi shares in Q2 2026, an estimated $9.44K.
Annis Gardner Whiting Capital Advisors first reported a position in Sanofi in Q3 2023 and held it in 11 quarters.
Annis Gardner Whiting Capital Advisors's Sanofi position peaked at $48.9K in Q2 2025.
718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.